Therapeutic potential of spironolactone in ankylosing spondylitis patients: Relation to disease activity and functional status
Aim of the work: Spironolactone with its anti-inflammatory and immunomodulatory properties due to inhibition of nuclear factor kappa B could have a therapeutic potential in ankylosing spondylitis (AS). The aim was to study the impact of spironolactone in active AS patients with an inadequate respons...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-04-01
|
| Series: | Egyptian Rheumatologist |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1110116420300855 |